Lipoplex-Mediated Deintercalation of Doxorubicin from Calf Thymus DNA–Doxorubicin Complex
- 26 August 2016
- journal article
- research article
- Published by American Chemical Society (ACS) in Langmuir
- Vol. 32 (35) , 8889-8899
Abstract
In the current effort, we reported the lipoplex mediated deintercalation of anticancer drug doxorubicin (DOX) from DOX-DNA complex under controlled experimental conditions. We used three zwitterionic liposomes namely DPPC, DMPC and POPC which are widely different in their phase transition temperature to form lipoplex with calf thymus DNA in presence of Ca2+ ions. The study revealed that DPPC being in sol-gel phase is more effective in releasing drug from DOX-DNA complex compared to liposomes that remain in liquid crystalline phase (DMPC and POPC). The higher extent of drug release in case of DPPC liposomes was attributed to the stronger lipoplex formation with DNA as compared to other liposomes. Owing to the relatively smaller head group area, DPPC liposomes in its sol gel phase can absorb larger number of Ca2+ ions and hence offer strong electrostatic interaction towards DNA. This interaction was confirmed by the time resolved anisotropy and circular dichroism spectroscopy. Apart from the electrostatic interaction, the possible hydrophobic interaction between liposomes and DNA was also taken into account for the observed deintercalation. The successful up taking of drug molecules by liposomes in the post release period from drug-DNA complex was also confirmed by confocal laser scanning microscopy (CLSM).Keywords
This publication has 67 references indexed in Scilit:
- Liposome: classification, preparation, and applicationsDiscover Nano, 2013
- Attenuation of Cytotoxic Natural Product DNA Intercalating Agents by CaffeineScientia Pharmaceutica, 2011
- Advances in gene delivery through molecular design of cationic lipidsChemical Communications, 2009
- Mitochondrial DNA is a direct target of anti-cancer anthracycline drugsBiochemical and Biophysical Research Communications, 2009
- Doxorubicin-DNA Adducts Induce a Non-Topoisomerase II–Mediated Form of Cell DeathCancer Research, 2006
- Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and CardiotoxicityPharmacological Reviews, 2004
- A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicinBiochemical Pharmacology, 1999
- Phase Behavior of Single DNA in Mixed SolventsJournal of the American Chemical Society, 1999
- Interaction of metal ions with phosphatidylcholine bilayer membranesBiochemistry, 1981
- Studies of the binding of actinomycin and related compounds to DNAJournal of Molecular Biology, 1968